We transform Australia & New Zealand's most promising medical discoveries into the latest medical therapies that save lives & improve quality of life, while generating returns for investors.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 40 companies to date.
The collaborative nature of the MRCF provides a supportive investment process, fostering best practice commercialisation and encouraging innovation. The MRCF works closely with its 50+ Member Institutes to identify promising opportunities with strong commercialisation potential.
The MRCF is unique, in that it is structured as a collaboration between the investors and the Member Institutes, with experienced representatives from each institute providing a ‘peer review’ assessment of opportunities through representation on the Investment Review Committee (IRC).
The MRCF works closely with the Member Institutes to identify promising opportunities, ‘working them up’, completing due diligence and establishing the start-up company. Most importantly, the MRCF guides the early stage investments through the development process to a trade-sale, partnering, next round financing or into stand-alone, growing businesses.